DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE BLOCKS COMPETITION IN THE PRESCRIPTION DRUG MARKET, KEEPS DRUG PRICES HIGH
Senate Hearing Offers Opportunity to Highlight Market-Based Solutions to Hold… Read More
Senate Hearing Offers Opportunity to Highlight Market-Based Solutions to Hold… Read More
Analysis Showcases Egregious Scale of Big Pharma’s Patent Thickets on… Read More
Analysis Shows Price Hikes Outpacing Inflation, Rising Launch Prices and… Read More
Repeated Price Hikes and Egregious Prices on GLP-1 Weight Loss Drugs Boost… Read More
Reports Find Biosimilars Have Lower Prices Than Brand Name Biologics… Read More
Big Pharma Continues Raking in Big Profits and Expectation-Beating Revenue… Read More
Two Reports Explore Cost for U.S. Patients and the U.S. Health Care System of… Read More
Big Pharma Giant Kicks Off Q1 Earnings After Hiking Prices More Than 40 Times… Read More
Big Pharma’s Announcements Designed to Deflect from Criticism and Scrutiny… Read More
CBO Says Cost to Taxpayers of Covering GLP-1 Medications Would Outpace Savings… Read More
Big Pharma Exec Downplays “Modest” Drug Pricing Solutions That CEO… Read More
Median Price Set by Brand Name Drug Makers on New Treatments Climbs to… Read More